Prosecution Insights
Last updated: August 18, 2026

Examiner: NESTOR, DONNA MICHELLE

Tech Center 1600 • Art Units: 1621 1622 1626 1627

This examiner grants 58% of resolved cases

Performance Statistics

57.7%
Allow Rate
-2.3% vs TC avg
110
Total Applications
+43.7%
Interview Lift
1166
Avg Prosecution Days
Based on 78 resolved cases, 2023–2026

Rejection Statute Breakdown

2.7%
§101 Eligibility
15.4%
§102 Novelty
35.2%
§103 Obviousness
25.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18294191 MICROBIOCIDAL PYRAZOLE DERIVATIVES Non-Final OA SYNGENTA CROP PROTECTION AG
18029982 MIXTURES CONTAINING CYCLOBUTRIFLURAM Final Rejection BASF SE
17995806 PI3 KINASE INHIBITORS AND USES THEREOF Final Rejection Purdue Research Foundation
18596363 TARGETED TREATMENT FOR SKIN FRAGILITY DISEASES Non-Final OA University of Washington
17623060 COMPOSITIONS AND METHODS OF TREATING LIVER CANCERS Final Rejection The Johns Hopkins University
17996550 2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS Non-Final OA Bayer Aktiengesellschaft
17767018 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES Final Rejection Bayer Aktiengesellschaft
18262053 ARTEMISININ-PROTEASOME INHIBITOR CONJUGATES AND THEIR USE IN THE TREATMENT OF DISEASE Final Rejection CORNELL UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month